Purpose: The deep learning time-of-flight (DL-ToF) aims to replicate the ToF effects through post-processing, applying deep learning-based enhancement to PET images. This study evaluates the effectiveness of DL-ToF using a chest-abdomen phantom that simulates human anatomical structures.
Methods: The 3 DL-ToF intensities (Low-DL-ToF: LDL, Middle-DL-ToF: MDL, High-DL-ToF: HDL) were adopted for the PET image of the chest-abdomen phantom. We assessed the mean SUV of the liver, kidneys, and soft tissue, as well as the maximum SUV of lung and liver tumors. Additionally, non-ToF images were subjected to 3 types of filtering. Texture analysis and shape index maps were used to evaluate filter effects.
Results: No significant differences were observed in the mean SUV between the 3 DL-ToF and non-ToF images. LDL sharpened lung tumors and smoothed liver tumors, while HDL exhibited more pronounced sharpening effects.
Conclusion: The DL-ToF produces image effects similar to ToF in PET imaging.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.6009/jjrt.25-1518 | DOI Listing |
J Pers Med
December 2024
Department of Radiology, University Hospital Tuebingen, 72076 Tübingen, Germany.
: Current guidelines recommend Cisplatin/Gemcitabine/Durvalumab as first-line treatment for inoperable or recurrent cholangiocarcinoma (CCA). Molecular tumor boards (MTB) have the expertise to support organ-specific tumor boards with evidence-based treatment recommendations for subsequent lines of treatment, based on genomic tumor data and scientific evidence. This study evaluates the adoption of an MTB at a comprehensive cancer center in Germany and whether actionable genetic alterations are associated with specific imaging phenotypes.
View Article and Find Full Text PDFCurr Issues Mol Biol
November 2024
Internal Medicine Clinic "Akta Medica", 11000 Belgrade, Serbia.
Lung cancer represents the most common cause of cancer-related death. Patients with non-small cell lung cancer (NSCLC) and liver metastases have worse prognosis, with an overall survival (OS) from three to six months. The majority of them have a poor response to chemotherapy, and the data are controversial regarding the response to immunotherapy.
View Article and Find Full Text PDFCurr Issues Mol Biol
November 2024
Internal Medicine Clinic "Akta Medica", 11000 Belgrade, Serbia.
Lung cancer represents the most common cause of cancer related death. Patients with non-small cell lung cancer (NSCLC) and liver metastases (LM) have worse prognosis with an overall survival (OS) of three to six months. The aim of this study was to investigate long-term outcomes in patients with EGFR mutated (EGFRmut) lung adenocarcinoma as well as the presence of LM.
View Article and Find Full Text PDFCurr Oncol
December 2024
Department of Radiation Oncology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan.
Most abscopal effects are reported as sporadic and unpredictable events following radiotherapy at symptomatic sites. Herein, we report a case in which a planned abscopal effect was induced following deliberate radiotherapy and concurrent systemic immunotherapy. A 53-year-old man with a combined positive score ≥10 developed extensive metastatic bladder cancer after progressing on conventional chemotherapy.
View Article and Find Full Text PDFNat Prod Res
December 2024
Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
The medicinal and commercial value of pomegranate peel is attributed to its rich content of phenolic compounds, yet little is known about their concentrations and biological activity across different ripening stages. Pomegranate peels at different growth stages 1-3 (40, 80, and 120 days after fruit appearance respectively) were collected, dried, and macerated with 90% methanol. Stage 2 and stage 3 extract showed significant antimicrobial activity against , and .
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!